← All MEPs

Pascal Arimont

European Parliament · EPP · 🇧🇪 Belgium

Term: since 18 July 2019

Participation in roll-call votes

98 % of the 2,540 roll-call votes held during their term: took part in the vote (for, against or abstention)

Participation month by month

0 % 50 % 100 % July 2019 : participation 100 % (1 / 1), presence 100 % (1 / 1) 2019 September 2019 : participation 100 % (5 / 5), presence 100 % (5 / 5) October 2019 : participation 100 % (19 / 19), presence 100 % (19 / 19) November 2019 : participation 100 % (18 / 18), presence 100 % (18 / 18) December 2019 : participation 100 % (6 / 6), presence 100 % (6 / 6) January 2020 : participation 100 % (12 / 12), presence 100 % (12 / 12) 2020 February 2020 : participation 88 % (7 / 8), presence 88 % (7 / 8) May 2020 : participation 100 % (54 / 54), presence 100 % (54 / 54) June 2020 : participation 100 % (12 / 12), presence 100 % (12 / 12) July 2020 : participation 100 % (19 / 19), presence 100 % (19 / 19) September 2020 : participation 100 % (24 / 24), presence 100 % (24 / 24) October 2020 : participation 100 % (37 / 37), presence 100 % (37 / 37) November 2020 : participation 100 % (32 / 32), presence 100 % (32 / 32) December 2020 : participation 100 % (30 / 30), presence 100 % (30 / 30) January 2021 : participation 100 % (23 / 23), presence 100 % (23 / 23) 2021 February 2021 : participation 100 % (21 / 21), presence 100 % (21 / 21) March 2021 : participation 100 % (31 / 31), presence 100 % (31 / 31) April 2021 : participation 100 % (81 / 81), presence 100 % (81 / 81) May 2021 : participation 100 % (26 / 26), presence 100 % (26 / 26) June 2021 : participation 100 % (29 / 29), presence 100 % (29 / 29) July 2021 : participation 100 % (27 / 27), presence 100 % (27 / 27) September 2021 : participation 100 % (19 / 19), presence 100 % (19 / 19) October 2021 : participation 100 % (42 / 42), presence 100 % (42 / 42) November 2021 : participation 100 % (27 / 27), presence 100 % (27 / 27) December 2021 : participation 100 % (29 / 29), presence 100 % (29 / 29) January 2022 : participation 100 % (7 / 7), presence 100 % (7 / 7) 2022 February 2022 : participation 100 % (29 / 29), presence 100 % (29 / 29) March 2022 : participation 100 % (37 / 37), presence 100 % (37 / 37) April 2022 : participation 100 % (22 / 22), presence 100 % (22 / 22) May 2022 : participation 100 % (88 / 88), presence 100 % (88 / 88) June 2022 : participation 100 % (46 / 46), presence 100 % (46 / 46) July 2022 : participation 100 % (31 / 31), presence 100 % (31 / 31) September 2022 : participation 100 % (25 / 25), presence 100 % (25 / 25) October 2022 : participation 100 % (32 / 32), presence 100 % (32 / 32) November 2022 : participation 100 % (38 / 38), presence 100 % (38 / 38) December 2022 : participation 94 % (17 / 18), presence 94 % (17 / 18) January 2023 : participation 94 % (15 / 16), presence 94 % (15 / 16) 2023 February 2023 : participation 100 % (29 / 29), presence 100 % (29 / 29) March 2023 : participation 100 % (29 / 29), presence 100 % (29 / 29) April 2023 : participation 100 % (24 / 24), presence 100 % (24 / 24) May 2023 : participation 100 % (93 / 93), presence 100 % (93 / 93) June 2023 : participation 98 % (39 / 40), presence 98 % (39 / 40) July 2023 : participation 100 % (40 / 40), presence 100 % (40 / 40) September 2023 : participation 63 % (17 / 27), presence 63 % (17 / 27) October 2023 : participation 98 % (39 / 40), presence 98 % (39 / 40) November 2023 : participation 100 % (53 / 53), presence 100 % (53 / 53) December 2023 : participation 100 % (40 / 40), presence 100 % (40 / 40) January 2024 : participation 98 % (48 / 49), presence 98 % (48 / 49) 2024 February 2024 : participation 98 % (62 / 63), presence 98 % (62 / 63) March 2024 : participation 100 % (50 / 50), presence 100 % (50 / 50) April 2024 : participation 100 % (213 / 213), presence 100 % (213 / 213) July 2024 : participation 100 % (1 / 1), presence 100 % (1 / 1) September 2024 : participation 88 % (7 / 8), presence 88 % (7 / 8) October 2024 : participation 85 % (11 / 13), presence 85 % (11 / 13) November 2024 : participation 100 % (27 / 27), presence 100 % (27 / 27) December 2024 : participation 100 % (18 / 18), presence 100 % (18 / 18) January 2025 : participation 100 % (6 / 6), presence 100 % (6 / 6) 2025 February 2025 : participation 100 % (10 / 10), presence 100 % (10 / 10) March 2025 : participation 100 % (14 / 14), presence 100 % (14 / 14) April 2025 : participation 100 % (22 / 22), presence 100 % (22 / 22) May 2025 : participation 98 % (53 / 54), presence 98 % (53 / 54) June 2025 : participation 95 % (21 / 22), presence 95 % (21 / 22) July 2025 : participation 0 % (0 / 32), presence 0 % (0 / 32) September 2025 : participation 100 % (29 / 29), presence 100 % (29 / 29) October 2025 : participation 100 % (45 / 45), presence 100 % (45 / 45) November 2025 : participation 100 % (51 / 51), presence 100 % (51 / 51) December 2025 : participation 97 % (30 / 31), presence 97 % (30 / 31) January 2026 : participation 100 % (22 / 22), presence 100 % (22 / 22) 2026 February 2026 : participation 96 % (27 / 28), presence 96 % (27 / 28) March 2026 : participation 95 % (42 / 44), presence 95 % (42 / 44) April 2026 : participation 100 % (51 / 51), presence 100 % (51 / 51) May 2026 : participation 100 % (25 / 25), presence 100 % (25 / 25) June 2026 : participation 100 % (35 / 35), presence 100 % (35 / 35) July 2026 : participation 100 % (35 / 35), presence 100 % (35 / 35) September 2026 : participation 100 % (40 / 40), presence 100 % (40 / 40) October 2026 : participation 100 % (53 / 53), presence 100 % (53 / 53) November 2026 : participation 100 % (13 / 13), presence 100 % (13 / 13)

Their votes

2,540 votes

DateTextResultTheir vote
Iran, in particular the case of 2012 Sakharov Prize Laureate Nasrin Sotoudeh For
Forced labour and the situation of the Uyghurs in the Xinjiang Uyghur Autonomous Region For
The Council Recommendation on vocational education and training (VET) for sustainable competitiveness, social fairness and resilience For
Sustainable corporate governance For
A strong social Europe for Just Transition - Communication from the Commission For
The European Citizens’ Initiative ‘Minority SafePack – one million signatures for diversity in Europe’ For
Mechanisms for control by Member States of the Commission’s exercise of implementing powers: implementing acts at appeal committee level For
The deteriorating situation of human rights in Egypt, in particular the case of the activists of the Egyptian Initiative for Personal Rights (EIPR) Against
The deteriorating situation of human rights in Egypt, in particular the case of the activists of the Egyptian Initiative for Personal Rights (EIPR) Against
Implementation report on the Return Directive For
Implementation of the Dublin III Regulation For
The Multiannual Financial Framework 2021-2027, the Interinstitutional Agreement, the EU Recovery Instrument and the Rule of Law Regulation For
A new strategy for European SMEs For
The EU Trade Policy Review For
Resolution on the de facto ban on the right to abortion in Poland For
Temporary measures in relation to value added tax for COVID-19 vaccines and in vitro diagnostic medical devices For
Export of certain dual-use items from the EU to the United Kingdom For
Elimination of customs duties on certain products For
Scalating tensions in Varosha following the illegal actions by Turkey and the urgent need for the resumption of talks For
The continuous violations of human rights in Belarus, in particular the murder of Roman Bondarenko For
The situation in Ethiopia For
The deteriorating situation of human rights in Algeria, in particular the case of journalist Khaled Drareni For
Situation of Fundamental Rights in the European Union - Annual Report for the years 2018-2019 For
Stocktaking of European elections For
The draft Commission implementing regulation approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10 For
Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate… For
Lead in gunshot in or around wetlands Against
Application of Union tariff rate quotas and other import quotas For
Improving development effectiveness and efficiency of aid Abstention
Foreign policy consequences of the COVID-19 outbreak For
A New Industrial Strategy for Europe For
Strengthening Media Freedom: the Protection of Journalists in Europe, Hate Speech, Disinformation and the Role of Platforms For
Addressing product safety in the Single Market For
Towards a more sustainable single market for business and consumers For
Markets in financial instruments Abstention
Lead in gunshot in or around wetlands Against
The impact of COVID-19 measures on democracy, the rule of law and fundamental rights For
InvestEU Programme For
Sustainable Europe Investment Plan - How to finance the Green Deal For
Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”) For

Rows per page: 20 40 100 200 All